Disease | portal vein thrombosis |
Comorbidity | C0023890|cirrhosis |
Sentences | 21 |
PubMedID- 25845711 | Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis. |
PubMedID- 23810655 | The coagulation pattern and the determinants of portal vein thrombosis (pvt), both in patients with and without cirrhosis, are still largely unknown. |
PubMedID- 21127694 | portal vein thrombosis in a patient with hcv cirrhosis and combined hemophilia a and thrombophilia v leiden. |
PubMedID- 25511529 | portal vein thrombosis occurs frequently in patients with cirrhosis, but it is unclear whether it is a cause or consequence of decompensation in cirrhosis. |
PubMedID- 26080307 | Therefore, the indications and effects of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis remain uncertain. |
PubMedID- 20666991 | Background: extrahepatic portal vein thrombosis, not associated with cirrhosis or tumours, is the second most frequent cause of portal hypertension worldwide. |
PubMedID- 25701619 | Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension. |
PubMedID- 24890816 | Procoagulant abnormalities in cirrhosis with portal vein thrombosis. |
PubMedID- 19864937 | Impact of antithrombin iii concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. |
PubMedID- 22472055 | Conclusions: early anticoagulation treatment in cirrhosis patients with portal vein thrombosis and acute variceal bleeding may be safe, tolerated, and effective in cases with positive intra-thrombus enhancement on contrast ultrasonography. |
PubMedID- 25759969 | Advanced cirrhosis combined with portal vein thrombosis: a randomized trial of ps versus endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding. |
PubMedID- 19464131 | Conclusion: ceus seems to be the pretty sensitive and specific test for diagnosing malignant portal vein thrombosis in patients with cirrhosis and tumors. |
PubMedID- 20932597 | Background & aims: data on the management of portal vein thrombosis (pvt) in patients with decompensated cirrhosis are extremely limited, particularly in the cases of the transjugular intrahepatic portosystemic shunt (tips). |
PubMedID- 19863496 | Background: as current imaging techniques in cirrhosis allow detection of asymptomatic portal vein thrombosis during routine ultrasonography, more patients with cirrhosis are diagnosed with portal vein thrombosis. |
PubMedID- 21190093 | Other reported cases of malignant portal vein thrombosis have been in patients with underlying hepatoma, cirrhosis, or with intrabiliary hepatocelluar carcinoma. |
PubMedID- 21310200 | There are indications that the risk for development of portal vein thrombosis in patients with advanced liver cirrhosis might be increased under therapy with thrombopoietin receptor agonists. |
PubMedID- 25013680 | In the presence of cirrhosis with portal vein thrombosis, liver transplantation can still be done in combination with thrombectomy or use of intervening jump graft. |
PubMedID- 24829653 | They suggested predisposition to hcc due to integration of hbv genome into host genome during intrauterine life.16 although development of portal vein thrombosis in a patient with cirrhosis can be explained, however the presence of both cirrhosis and hepatocellular carcinoma in a young adult with isolated hbv infection is very unusual. |
PubMedID- 19730112 | Background: treatment of portal vein thrombosis (pvt) in patients with liver cirrhosis is not well established. |
PubMedID- 21054520 | Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc). |
PubMedID- 25013592 | Explanted liver pathology had mixed macro- and micro-nodular cirrhosis with portal vein thrombosis. |
Page: 1